Package 76282-115-60

{"route": ["ORAL"], "spl_id": "9d9239ba-eadd-45f3-a528-f9e2f7e2db04", "openfda": {"nui": ["N0000175656", "N0000175462", "N0000009947"], "upc": ["0376282115603"], "unii": ["2T8Q726O95", "4B9XT59T7S"], "rxcui": ["200082"], "spl_set_id": ["4cf565c3-bdec-4c18-93c1-cc7fa8331c90"], "pharm_class_epc": ["Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]", "Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]"], "pharm_class_moa": ["Nucleoside Reverse Transcriptase Inhibitors [MoA]"], "manufacturer_name": ["Exelan Pharmaceuticals Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "500 TABLET, FILM COATED in 1 BOTTLE (76282-115-05)", "package_ndc": "76282-115-05", "marketing_start_date": "20150429"}, {"sample": false, "description": "60 TABLET, FILM COATED in 1 BOTTLE (76282-115-60)", "package_ndc": "76282-115-60", "marketing_start_date": "20150429"}], "brand_name": "Lamivudine and Zidovudine", "product_id": "76282-115_9d9239ba-eadd-45f3-a528-f9e2f7e2db04", "dosage_form": "TABLET, FILM COATED", "pharm_class": ["Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]", "Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]", "Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]", "Nucleoside Analog [EXT]", "Nucleoside Analog [EXT]", "Nucleoside Reverse Transcriptase Inhibitors [MoA]", "Nucleoside Reverse Transcriptase Inhibitors [MoA]"], "product_ndc": "76282-115", "generic_name": "Lamivudine and Zidovudine", "labeler_name": "Exelan Pharmaceuticals Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Lamivudine and Zidovudine", "active_ingredients": [{"name": "LAMIVUDINE", "strength": "150 mg/1"}, {"name": "ZIDOVUDINE", "strength": "300 mg/1"}], "application_number": "ANDA203259", "marketing_category": "ANDA", "marketing_start_date": "20150429", "listing_expiration_date": "20261231"}